What’s it to You? Justice Scalia’s 41-Year-Old Gatekeeping Question on “Standing” Influences Court to Uphold FDA’s Regulation of Mifepristone

Start
Mifepristone is safe for now. On June 13, 2024, the Supreme Court unanimously held that the plaintiffs — doctors and medical associations alike — lacked standing to challenge 2000 and 2019 FDA approvals of mifepristone (brand name: Mifeprex), a drug used to terminate pregnancies through ten weeks gestation. Avoiding a substantive decision on the merits of the plaintiffs’ case, the Court held that the plaintiffs’ legal and moral objections to elective abortion and the FDA’s increasingly relaxed…
By: Akerman LLP – Health Law Rx
Previous Story

Developments Toward Standardizing AI ‘Red Teaming’

Next Story

Top 10 Windows productivity tips